Cargando…

Sales of macrolides, lincosamides, streptogramins, and amoxicillin/clavulanate in the in- and outpatient setting in 10 European countries, 2007–2010

Monitoring the use of antibiotics is relevant due to the public health impact of microbial resistance, adverse effects, and costs. We present data on the consumption of macrolides, lincosamides, streptogramins and amoxicillin/clavulanate (AMC) between 2007 and 2010 in the in-and outpatient healthcar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferrer, Pili, Sabaté, Mònica, Ballarín, Elena, Fortuny, Joan, Rottenkolber, Marietta, Schmiedl, Sven, Laporte, Joan-Ramon, Ibáñez, Luisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628133/ https://www.ncbi.nlm.nih.gov/pubmed/26543747 http://dx.doi.org/10.1186/s40064-015-1398-4

Ejemplares similares

Environmental Macrolide–Lincosamide–Streptogramin and Tetracycline Resistant Bacteria
por: Roberts, Marilyn C.
Publicado: (2011)

New Gene Responsible for Resistance of Clinical Corynebacteria to Macrolide, Lincosamide and Streptogramin B
por: SZEMRAJ, MAGDALENA, et al.
Publicado: (2018)

Heterogeneity of macrolide-lincosamide-streptogramin phenotype & conjugal transfer of erm(B) in Pediococcus pentosaceus
por: Thumu, Surya Chandra Rao, et al.
Publicado: (2019)

Incidence of macrolide–lincosamide–streptogramin B resistance amongst beta-haemolytic streptococci in The Gambia
por: Foster-Nyarko, Ebenezer, et al.
Publicado: (2017)

Novel macrolide-lincosamide-streptogramin B resistance gene erm(56) in Trueperella pyogenes
por: Marchionatti, Emma, et al.
Publicado: (2023)

Consumption of macrolides, lincosamides and streptogramins in the community, European Union/European Economic Area, 1997–2017
por: Adriaenssens, Niels, et al.
Publicado: (2021)

Molecular basis of resistance to macrolides, lincosamides and streptogramins in Staphylococcus hominis strains isolated from clinical specimens
por: Szczuka, Ewa, et al.
Publicado: (2015)

Analysis of Resistance to Macrolide–Lincosamide–Streptogramin B Among mecA-Positive Staphylococcus Aureus Isolates
por: Khodabandeh, Mahmoud, et al.
Publicado: (2019)

A compilation of research working groups on drug utilisation across Europe
por: Sabaté, Mònica, et al.
Publicado: (2014)

Phenotypic and genotypic characterization of macrolide, lincosamide and streptogramin B resistance among clinical isolates of staphylococci in southwest of Iran
por: Khashei, Reza, et al.
Publicado: (2018)

Clinical Resistant Strains of Enterococci and Their Correlation to Reduced Susceptibility to Biocides: Phenotypic and Genotypic Analysis of Macrolides, Lincosamides, and Streptogramins
por: Abu Lila, Amr Selim, et al.
Publicado: (2023)

Optimization of loop-mediated isothermal amplification-based method for detection of macrolide–lincosamide–streptogramin B resistance in Staphylococcus aureus
por: Deshamukhya, Chandrayee, et al.
Publicado: (2023)

Phenotypic and genotypic study of macrolide, lincosamide and streptogramin B (MLS(B)) resistance in clinical isolates of Staphylococcus aureus in Tehran, Iran
por: Saderi, Horieh, et al.
Publicado: (2011)

The prevalence of genotypes that determine resistance to macrolides, lincosamides, and streptogramins B compared with spiramycin susceptibility among erythromycin-resistant Staphylococcus epidermidis
por: Juda, Marek, et al.
Publicado: (2016)

High-Level Resistance of Toxigenic Clostridioides difficile Genotype to Macrolide-Lincosamide- Streptogramin B in Community Acquired Patients in Eastern China
por: Zhao, Longyou, et al.
Publicado: (2020)

Phenotypic and Genotypic Characterization of Macrolide, Lincosamide and Streptogramin B Resistance among Clinical Methicillin-Resistant Staphylococcus aureus Isolates in Chile
por: Quezada-Aguiluz, Mario, et al.
Publicado: (2022)

Macrolide-lincosamide-streptogramin resistance phenotypes and genotypes of coagulase-positive Staphylococcus aureus and coagulase-negative staphylococcal isolates from bovine mastitis
por: Li, Longping, et al.
Publicado: (2015)

Staphylococcus aureus with an erm-mediated constitutive macrolide-lincosamide-streptogramin B resistance phenotype has reduced susceptibility to the new ketolide, solithromycin
por: Yao, Weiming, et al.
Publicado: (2019)

Prevalence of methicillin resistance and macrolide–lincosamide–streptogramin B resistance in Staphylococcus haemolyticus among clinical strains at a tertiary-care hospital in Thailand
por: Teeraputon, S., et al.
Publicado: (2017)

Phenotypic and molecular characterization of resistance to macrolides, lincosamides and type B streptogramin of clinical isolates of Staphylococcus spp. of a university hospital in Recife, Pernambuco, Brazil
por: Pereira, Jussyêgles Niedja da Paz, et al.
Publicado: (2016)

An increase in erythromycin resistance in methicillin-susceptible Staphylococcus aureus from blood correlates with the use of macrolide/lincosamide/streptogramin antibiotics. EARS-Net Spain (2004–2020)
por: El Mammery, Achraf, et al.
Publicado: (2023)

A Low Prevalence of Inducible Macrolide, Lincosamide, and Streptogramin B Resistance Phenotype among Methicillin-Susceptible Staphylococcus aureus Isolated from Malaysian Patients and Healthy Individuals
por: Mesbah Elkammoshi, Asma, et al.
Publicado: (2016)

Detection and Genetic Environment of Pleuromutilin-Lincosamide-Streptogramin A Resistance Genes in Staphylococci Isolated from Pets
por: Deng, Fengru, et al.
Publicado: (2017)

Structural basis of ABCF-mediated resistance to pleuromutilin, lincosamide, and streptogramin A antibiotics in Gram-positive pathogens
por: Crowe-McAuliffe, Caillan, et al.
Publicado: (2021)

erm(T)-Mediated Macrolide-Lincosamide Resistance in Streptococcus suis
por: Yu, Rui, et al.
Publicado: (2022)

Prevalence of Genotypes That Determine Resistance of Staphylococci to Macrolides and Lincosamides in Serbia
por: Mišić, Milena, et al.
Publicado: (2017)

Myoclonus induced by amoxicillin-clavulanic acid
por: Viloria-Alebesque, Alejandro, et al.
Publicado: (2020)

Amoxicillin-Clavulanate-Induced Ischaemic Colitis
por: Alonge, Marco, et al.
Publicado: (2020)

Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
por: Rottenkolber, Marietta, et al.
Publicado: (2015)

Is the standard dose of amoxicillin-clavulanic acid sufficient?
por: Haeseker, Michiel, et al.
Publicado: (2014)

Drug Induced Autoimmune Hepatitis by Amoxicillin-Clavulanate
por: BARIŞ KUZU, Ufuk, et al.
Publicado: (2016)

Kounis syndrome associated with amoxicillin/clavulanic acid
por: Shimi, A, et al.
Publicado: (2016)

Evaluation of urine concentrations of amoxicillin and clavulanate in cats
por: KuKanich, Kate, et al.
Publicado: (2020)

Utilisation and Off-Label Prescriptions of Respiratory Drugs in Children
por: Schmiedl, Sven, et al.
Publicado: (2014)

Comparative trial between the use of amoxicillin and amoxicillin clavulanate in the removal of third molars
por: Iglesias-Martín, Fernando, et al.
Publicado: (2014)

Macrolides and associated antibiotics based on similar mechanism of action like lincosamides in malaria
por: Gaillard, Tiphaine, et al.
Publicado: (2016)

Treatment of Cervical Chlamydial Infection With Amoxicillin/Clavulanate Potassium
por: Mann, Melinda S., et al.
Publicado: (1993)

Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid
por: Lee, Soo-Yun, et al.
Publicado: (2015)

Amoxicillin/clavulanic acid-induced pancreatitis: case report
por: Chams, Sana, et al.
Publicado: (2018)

672. The Impact on Humans of Treating Dogs with Amoxicillin/Clavulanate
por: Beaulac, Kirthana R, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0ttfeesq79nfgnf81vfqfroikm